Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 10, 2015
Grant Date -
Dec 15, 2011
app pub date -
May 11, 2011
filing date -
May 13, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Heteroaryloxycarbocyclyl compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, Huntington's Disease, bipolar disorder, obsessive-compulsive disorder, and the like.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully